New Iridium has been selected as a finalist for Hello Tomorrow Global Challenge 2023 – Environmental track. Join us in Paris on March 8-10 for the event! Excerpt of the Hello Tomorrow press release: “THE 70 FINALISTS THAT WILL CHANGE THE WORLD…An international jury of experts carefully reviewed over 4000 applications to the Challenge, and…
New Iridium is pleased to announce the acceptance into 2023 REACH Energy Accelerator hosted by Innosphere Ventures. This program will boost our effort to commercialize our technology in producing low-carbon chemicals at lower cost. Press release excerpt: “Innosphere Ventures and Colorado State University (CSU) announce the fourteen startup and scaleup companies that have been selected…
New Iridium founder and CEO, Dr. Chern-Hooi Lim, was interviewed by Dr. Paolo Braiuca, Director of Global Market Development, Thermo Fisher Scientific for his Bringing Chemistry to Life Podcast Series. Excerpt from the episode abstract: “This is a fascinating discussion about the present and future of chemistry. We discover how photocatalysis enables a new paradigm…This…
New Iridium founder and CEO, Dr. Chern-Hooi Lim, was named to C&EN’s Talented 12 Class of 2021 by the industry’s top scientific body honoring early career chemists solving formidable global problems. Read Article
New Iridium was honored by The Biomimicry Institute (https://biomimicry.org) as a finalist for its 2021 Ray of Hope Prize. This prestigious award celebrates nature-inspired solutions addressing the world’s largest environmental and sustainability challenges. New Iridium was selected as a finalist from over 300 worldwide contestants. Read Article
New Iridium has launched a new set of photocatalysts that decrease the cost and safety risks associated with Birch Reductions. These photocatalysts allow for light-driven Birch Reductions under bench-top conditions; leading to safer scale-up reactions. New Iridium has licensed this set of products with Millipore Sigma. Read Article
Hosted by Colorado Bioscience Association, Dr. Chern-Hooi Lim participated in a panel on maximizing public-private partnerships to scale innovation. Read Article
Our Co-Founder and CEO, Dr. Chern-Hooi Lim sheds light on the uptake of New Iridium’s photocatalysis technology into the pharmaceutical industry. Read Article
New Iridium receives NSF Small Business Technology Transfer (STTR) grant to accelerate potential COVID-19 drug treatment, Remdesivir. We are using our photocatalytic technology to tackle this global issue and help treat people around the world suffering from COVID-19. Read Article
New Iridium was featured on Daily Camera as 1 of 6 Boulder-based startups with ties to the University of Colorado Boulder for all their innovation with $1.5 million in grants from the Colorado Office of Economic Development and International Trade (OEDIT). Read Article